Funding for this research was provided by:
PSC Partners Seeking a Cure
Text and Data Mining valid from 2020-01-03
Received: 9 August 2019
Accepted: 10 December 2019
First Online: 3 January 2020
Ethics approval and consent to participate
: All patients gave their written informed consent. Proteomic analyses were approved by the local ethical committee of Hannover Medical School.
: Not applicable.
: Harald Mischak is founder and co-owner and Jochen Metzger, Martin Pejchinovski, Agnieszka Latosinska and Maria Frantzi are employees of the biotechnology company mosaiques-diagnostics GmbH located in Hannover, Germany, which developed the bile and urine peptide marker patterns for cholangiocarcinoma diagnosis. All other authors have no competing interests.